February 17, 2014
Otsuka Pharmaceutical and the Danish-based H. Lundbeck announced on February 13 that Abilify Maintena (aripiprazole), a once-monthly, long-acting intramuscular injectable formulation of the antipsychotic agent Abilify, received regulatory approval in Canada on February 10. The drug is due to be...read more